Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials

✍ Scribed by Nout, R.A.; Peters, E.E.M.; Jürgenliemk-Schulz, Ì.M.; Jobsen, J.J.; Mens, J.W.M.; Stelloo, E.; Smit, V.T.H.; Bosse, T.; Creutzberg, C.L.

• Book ID: 127304410
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 73 KB
• Volume: 90
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2014.05.531